Video
PART 1: Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillation - Scope of the Problem and Key Challenges
Published: 21 May 2020
-
Views:
270
-
Likes:
1
Average (ratings)
No ratings
Prof Jan Steffel (Univerity He art Center, Zurich, CH), Prof Jur ten Berg (St Anthonius Hospital, Nieuwegein, NL) and Prof Stefan Hohnloser (JW Goethe University, Frankfurt, DE) discuss Dual vs Triple Anti-thrombotic Therapy for Post-PCI Patients with Atrial Fibrillaiton.
This discussion was funded by an unrestricted educational service from Boehringer Ingelheim